v3.25.4
DEBT AND CREDIT FACILITIES - Additional Information (Details)
$ in Millions
1 Months Ended 12 Months Ended
Feb. 28, 2025
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Jun. 30, 2024
USD ($)
Oct. 23, 2020
Debt Instrument [Line Items]            
Repayments of debt   $ 1,788 $ 1,970 $ 2,250    
Immunomedics, Inc. | Measurement Input, Expected Term            
Debt Instrument [Line Items]            
Liability related to future royalties, measurement Input           16
Senior notes            
Debt Instrument [Line Items]            
Redemption price, percentage   100.00%        
Redemption price, percentage of aggregate principal amount   101.00%        
Senior notes | Minimum            
Debt Instrument [Line Items]            
Par call term (in months)   1 month        
Senior notes | Maximum            
Debt Instrument [Line Items]            
Par call term (in months)   6 months        
Senior notes | 3.50% Senior Unsecured Notes Due in February 2025            
Debt Instrument [Line Items]            
Repayments of debt $ 1,750          
Line of credit | Revolving credit facility            
Debt Instrument [Line Items]            
Amounts outstanding under the facility   $ 0 $ 0      
Line of credit | Terminated 2020 Revolving Credit Facility | Revolving credit facility            
Debt Instrument [Line Items]            
Maximum borrowing capacity         $ 2,500  
Line of credit | 2024 Revolving Credit Facility | Revolving credit facility            
Debt Instrument [Line Items]            
Maximum borrowing capacity         $ 2,500